EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease

Masayuki Takahira, Hiroshi Goto, Atsushi Azumi

Japanese Journal of Ophthalmology · 2024-07 · 68 (4) · 293-301

DOI: 10.1007/s10384-024-01072-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Japanese Journal of Ophthalmology, online erschienen am 22.07.2024. Verfasst von Masayuki Takahira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. takahira@med.kanazawa-u.ac.jp. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Immunoglobulin G. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kanazawa University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin G4 (IgG4)-related disease is a clinical entity characterized by elevated serum IgG4 concentrations and infiltration of IgG4-immunopositive plasmacytes in various organs, including ophthalmic lesions. Diagnostic criteria for IgG4-related ophthalmic disease (IgG4-ROD) were established in 2014 and describe the most affected ocular adnexal tissues such as lacrimal glands, trigeminal nerves and extraocular muscles, but do not mention optic neuropathy, the most severe indication of ophthalmic lesions. We reviewed published case reports of optic neuropathy in IgG4-related disease ( n = 44), and in many cases, decreased visual acuities recovered well following treatment such as systemic corticosteroids, rituximab, and orbital surgery. However, some patients did not recover, especially when pretreatment visual acuities were as low as light perception or less. Herein, we propose a 2023 revised diagnostic criteria for IgG4-ROD, which include a reminder not to overlook optic neuropathy. The 2014 diagnostic criteria specify mucosa-associated lymphoid tissue (MALT) lymphoma as an important differential diagnosis for the relationship between IgG4-ROD and orbital lymphoma. The 2023 revision directs physicians’ attention toward lymphomas other than MALT lymphoma, considering that the 2014 criteria might have placed too much emphasis on MALT lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin G4-Related DiseaseImmunoglobulin GHumansDiagnosis, DifferentialEye DiseasesOptic Nerve Diseases

Stichwörter der Autor:innen

IgG4-related diseaseIgG4-related ophthalmic diseaseLacrimal glandMALT lymphomaOptic neuropathy

Substanzen

Immunoglobulin G

Autor:innen und Institutionen

  • Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. takahira@med.kanazawa-u.ac.jp.
  • Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan.
  • Department of Ophthalmology, Kobe Kaisei Hospital, Hyogo, Japan.

Förderung

  • Kanazawa University

Zitieren

APA

Takahira, M., Goto, H., & Azumi, A. (2024). The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Japanese Journal of Ophthalmology, 68(4), 293-301. https://doi.org/10.1007/s10384-024-01072-4

Vancouver

Takahira M, Goto H, Azumi A. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Japanese Journal of Ophthalmology. 2024;68(4):293-301. doi:10.1007/s10384-024-01072-4

BibTeX
@article{Takahira2024,
  author = {Takahira, Masayuki and Goto, Hiroshi and Azumi, Atsushi},
  title = {The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease},
  journal = {Japanese Journal of Ophthalmology},
  year = {2024},
  volume = {68},
  number = {4},
  pages = {293--301},
  doi = {10.1007/s10384-024-01072-4}
}
Kostenlos starten →